Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles

October 24, 2019 Leave a comment 1,166 Views

Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today that it has been awarded a contract with National Institute of Allergy and Infectious...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NIAID

Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles

Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition

Codiak presents data demonstrating potential of engineered exosomes

Featured Exosome Job – Research Associate, College of Engineering and Applied Science

Exosomes as new therapeutic vectors for pancreatic cancer treatment

Monitoring durability of microRNA-based gene therapies in the central nervous system with extracellular vesicles

Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA